Company News for September 11, 2009

• Merck (NYSE:MRK) announced its plans to abandon an experimental treatment for migraines and to review Phase III clinical data on another migraine drug

• Morgan Stanley's (NYSE:MS) CEO John Mack will be replaced before year-end by current co-president James Gorman

• Abbott Labs (NYSE:ABT) announced that it bought the 90% of Evalve that it does not already own for $410 million

• Bank of America (NYSE:BAC) cut its rating on Electronic Arts (NASDAQ:ERTS) to "neutral"

• Wells Fargo (NYSE:WFC) lowered its rating on AIG (NYSE:AIG) to "underperform" asserting the firm currently is trading "significantly" above book value

• National Semiconductor (NYSE:NSM) reported fiscal first quarter earnings of 13 cents a share, 6 cents above estimates on revenues of $314 million

Read the full analyst report on MRK

Read the full analyst report on MS

Read the full analyst report on ABT

Read the full analyst report on BAC

Read the full analyst report on ERTS

Read the full analyst report on WFC

Read the full analyst report on AIG

Read the full analyst report on NSM